Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04907136 · ClinicalTrials.gov registry record · NA
Developing and Testing Health Warning Labels on the ENDS Device
A NA study of Electronic Cigarette Use, sponsored by Florida International University.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT04907136: Recruiting NA study of Electronic Cigarette Use, sponsored by Florida International University.
NCT04907136 is a NA study of Electronic Cigarette Use that is actively recruiting participants, run by Florida International University. The registered enrollment target is 80 participants, below the 207-participant average among 15 other Electronic Cigarette Use trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04907136, a NA study of Electronic Cigarette Use, is actively recruiting participants, sponsored by Florida International University.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
In this project, after systematically developing electronic nicotine delivery systems (ENDS) pictorial health warning labels (HWLs), a proven clinical lab model will be used to examine and test their effect when these are placed on the ENDS device on a variety of subjective (e.g. satisfaction, harm perception, nicotine dependence, intention to quit) and objective outcomes (e.g. plasma nicotine, puff topography) in young adults.
Primary Outcome
Change in plasma nicotine level
Conditions Studied
Interventions
- OTHER Preferred ENDS
- OTHER Preferred ENDS with HWL
Study Locations (1)
Florida
- Florida International University - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-12-13 |
| Est. Completion | 2027-04-30 |
| Phase | NA |
What NCT04907136 shows while recruiting
NCT04907136 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 207-participant average among 15 other Electronic Cigarette Use trials with a reported enrollment target (61% lower).
The record links to 1 condition, with Electronic Cigarette Use appearing as the primary indexed condition, and to 2 interventions - of which Preferred ENDS is the first listed.
NCT04907136 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04907136 about?
NCT04907136 is a clinical study titled "Developing and Testing Health Warning Labels on the ENDS Device". In this project, after systematically developing electronic nicotine delivery systems (ENDS) pictorial health warning labels (HWLs), a proven clinical lab model will be used to examine and test their effect when these are placed on the ENDS device on a variety of subjective (e.g. satisfaction, harm ...
What is the current status of trial NCT04907136?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-12-13. Estimated completion is 2027-04-30.
What conditions does trial NCT04907136 study?
This clinical trial studies the following conditions: Electronic Cigarette Use.
What interventions are being tested in trial NCT04907136?
The interventions under investigation include: Preferred ENDS (OTHER), Preferred ENDS with HWL (OTHER).
Who is sponsoring clinical trial NCT04907136?
This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04907136 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Electronic Cigarette Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04907136's enrollment target sits among peer trials
80 9th of 15 higher than 7 of 15 other Electronic Cigarette Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Electronic Cigarette Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Social Media Use on Young Adults' E-Cigarette Use
RECRUITING · NA
-
Switching Individuals in Treatment for Opioid Use Disorder Who Smoke Cigarettes to the SREC
RECRUITING · NA
-
Effect of Menthol on ENDS Users' Addiction and Exposure
RECRUITING · NA
-
Development of UP2UTobacco for High School Youth
ACTIVE NOT RECRUITING · NA
-
PACE Vape Messaging Study
COMPLETED · NA
-
Assessing Electronic Cigarette Nicotine Flux
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI